Literature DB >> 26033325

Tocilizumab and steroid boli for treatment-resistant anterior necrotizing scleritis.

Jan Tode1, Rainald Zeuner2, Mark Saeger1, Johann Roider1, Bernhard Nölle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26033325     DOI： 10.1111/aos.12720

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  2 in total

1.  New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy.

Authors:  Claudia Fabiani; Jurgen Sota; Maite Sainz-de-la-Maza; Laura Pelegrín; Giacomo Emmi; Giuseppe Lopalco; Florenzo Iannone; Lorenzo Vannozzi; Silvana Guerriero; Maria Chiara Gelmi; Donato Rigante; Gian Marco Tosi; José Hernández-Rodríguez; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2020-01-17       Impact factor: 4.711

Review 2.  Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

Authors:  Jurgen Sota; Matteo-Maria Girolamo; Bruno Frediani; Gian Marco Tosi; Luca Cantarini; Claudia Fabiani
Journal:  Ophthalmol Ther       Date:  2021-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.